From junk to master regulators of invasion: LncRNA functions in migration, EMT and metastasis

International Journal of Cancer

Volumn 139, Issue 2, 2016, Pages 269-280

  Dhamija, Sonam ^a,b,c   Diederichs, Sven ^a,b,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

cancer; EMT; lncRNA; MALAT1; metastasis; noncoding RNA

Indexed keywords

COLON CANCER ASSOCIATED TRANSCRIPT 2 RNA; HOX TRANSCRIPT ANTISENSE INTERGENIC RNA; LINCRNA REGULATOR OF REPROGRAMMING; LNCRNA ACTIVATED BY TGF BETA; LNCRNA T CELL FACTOR 7; LONG UNTRANSLATED RNA; LOW EXPRESSION IN TUMOR RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1 RNA; NEUROBLASTOMA ASSOCIATED TRANSCRIPT 1 RNA; NUCLEAR FACTOR KAPPA B INTERACTING LNCRNA; SECOND CHROMOSOME LOCUS ASSOCIATED WITH PROSTATE 1 RNA; TRANSLATIONAL REGULATORY LNCRNA; UNCLASSIFIED DRUG; UROTHELIAL CANCER ASSOCIATED 1 RNA; ZEB2 ANTISENSE RNA 1; BIOLOGICAL MARKER;

ALTERNATIVE RNA SPLICING; BLADDER CANCER; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; COLORECTAL CANCER; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; NEUROBLASTOMA; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TRANSLATION REGULATION; TUMOR GROWTH; TUMOR INVASION; ANIMAL; CELL MOTION; CELL TRANSFORMATION; DISEASE COURSE; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BIOMARKERS; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; RNA, LONG NONCODING; SIGNAL TRANSDUCTION;

EID: 84959493857     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30039     Document Type: Review

References (174)

1. Sethi N, Kang Y., Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat Rev Cancer 2011; 11: 735-48.
2. Hanahan D, Weinberg RA., Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
3. Ye X, Weinberg RA., Epithelial-mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol 2015; 25: 675-86.
4. Lamouille S, Xu J, Derynck R., Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-96.
5. Simpson CD, Anyiwe K, Schimmer AD., Anoikis resistance and tumor metastasis. Cancer Lett 2008; 272: 177-85.
6. Spano D, Heck C, De Antonellis P, et al., Molecular networks that regulate cancer metastasis. Semin Cancer Biol 2012; 22: 234-49.
7. Ling H, Fabbri M, Calin GA., MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 2013; 12: 847-65.
8. Consortium EP, Birney E, Stamatoyannopoulos JA, et al., Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447: 799-816.
9. Djebali S, Davis CA, Merkel A, et al., Landscape of transcription in human cells. Nature 2012; 489: 101-8.
10. Derrien T, Johnson R, Bussotti G, et al., The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012; 22: 1775-89.
11. Batista PJ, Chang HY., Long noncoding RNAs: cellular address codes in development and disease. Cell 2013; 152: 1298-307.
12. Sauvageau M, Goff LA, Lodato S, et al., Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife 2013; 2: e01749
13. Gutschner T, Diederichs S., The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012; 9: 703-19.
14. Huarte M., The emerging role of lncRNAs in cancer. Nat Med 2015; 21: 1253-61.
15. Ji P, Diederichs S, Wang W, et al., MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003; 22: 8031-41.
16. Gutschner T, Hammerle M, Diederichs S., MALAT1-A paradigm for long noncoding RNA function in cancer. J Mol Med (Berl) 2013; 91: 791-801.
17. Gutschner T, Hammerle M, Eissmann M, et al., The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013; 73: 1180-9.
18. Yang L, Lin C, Liu W, et al., ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 2011; 147: 773-88.
19. Guo F, Li Y, Liu Y, et al., Inhibition of metastasis-Associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) 2010; 42: 224-9.
20. Xu C, Yang M, Tian J, et al., MALAT-1: a long non-coding RNA and its important 3′ end functional motif in colorectal cancer metastasis. Int J Oncol 2011; 39: 169-75.
21. Ying L, Chen Q, Wang Y, et al., Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 2012; 8: 2289-94.
22. Lai MC, Yang Z, Zhou L, et al., Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 2012; 29: 1810-6.
23. Arun G, Diermeier S, Akerman M, et al., Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev, in press.
24. West JA, Davis CP, Sunwoo H, et al., The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol Cell 2014; 55: 791-802.
25. Vassallo I, Zinn P, Lai M, et al., WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene 2015; 35: 12-21.
26. Zhao Y, Yang Y, Trovik J, et al., A novel wnt regulatory axis in endometrioid endometrial cancer. Cancer Res 2014; 74: 5103-17.
27. Xiao H, Tang K, Liu P, et al., LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Oncotarget 2015;.
28. Wang J, Wang H, Zhang Y, et al., Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer. Cell Signal 2014; 26: 1048-59.
29. Rinn JL, Kertesz M, Wang JK, et al., Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007; 129: 1311-23.
30. Niinuma T, Suzuki H, Nojima M, et al., Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 2012; 72: 1126-36.
31. Ding C, Cheng S, Yang Z, et al., Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells. Int J Mol Sci 2014; 15: 4060-76.
32. Kogo R, Shimamura T, Mimori K, et al., Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 2011; 71: 6320-6.
33. Gupta RA, Shah N, Wang KC, et al., Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-6.
34. Geng YJ, Xie SL, Li Q, et al., Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J Int Med Res 2011; 39: 2119-28.
35. Chen FJ, Sun M, Li SQ, et al., Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinog 2013; 52: 908-15.
36. Sorensen KP, Thomassen M, Tan Q, et al., Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer. Breast Cancer Res Treat 2013; 142: 529-36.
37. Tsai MC, Manor O, Wan Y, et al., Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329: 689-93.
38. Zhang A, Zhao JC, Kim J, et al., LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer. Cell Rep 2015; 13: 209-21.
39. Yang F, Zhang L, Huo XS, et al., Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011; 54: 1679-89.
40. Yang F, Huo XS, Yuan SX, et al., Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013; 49: 1083-96.
41. Ma MZ, Kong X, Weng MZ, et al., Long non-coding RNA-LET is a positive prognostic factor and exhibits tumor-suppressive activity in gallbladder cancer. Mol Carcinog 2015; 54: 1397-406.
42. Zhou B, Jing XY, Wu JQ, et al., Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer. Int J Clin Exp Pathol 2014; 7: 8893-8.
43. Unwith S, Zhao H, Hennah L, et al., The potential role of HIF on tumour progression and dissemination. Int J Cancer 2015; 136: 2491-503.
44. Prensner JR, Iyer MK, Sahu A, et al., The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex. Nat Genet 2013; 45: 1392-8.
45. Prensner JR, Zhao S, Erho N, et al., RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1. Lancet Oncol 2014; 15: 1469-80.
46. Mehra R, Shi Y, Udager AM, et al., A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer. Neoplasia 2014; 16: 1121-7.
47. Orom UA, Derrien T, Beringer M, et al., Long noncoding RNAs with enhancer-like function in human cells. Cell 2010; 143: 46-58.
48. Gavert N, Ben-Ze'ev A., Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 2008; 14: 199-209.
49. Gumireddy K, Li A, Yan J, et al., Identification of a long non-coding RNA-Associated RNP complex regulating metastasis at the translational step. Embo J 2013; 32: 2672-84.
50. Loewer S, Cabili MN, Guttman M, et al., Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 2010; 42: 1113-7.
51. Hou P, Zhao Y, Li Z, et al., LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis 2014; 5: e1287
52. Eades G, Wolfson B, Zhang Y, et al., lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. Mol Cancer Res 2015; 13: 330-8.
53. Fan J, Xing Y, Wen X, et al., Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis. Genome Biol 2015; 16: 139
54. Liu B, Sun L, Liu Q, et al., A cytoplasmic NF-kappaB interacting long noncoding RNA blocks IkappaB phosphorylation and suppresses breast cancer metastasis. Cancer Cell 2015; 27: 370-81.
55. Yuan JH, Yang F, Wang F, et al., A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell 2014; 25: 666-81.
56. Iguchi T, Uchi R, Nambara S, et al., A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Res 2015; 35: 1385-8.
57. Saito T, Kurashige J, Nambara S, et al., A Long Non-coding RNA Activated by Transforming Growth Factor-beta is an Independent Prognostic Marker of Gastric Cancer. Ann Surg Oncol 2015;.
58. Shi SJ, Wang LJ, Yu B, et al., LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget 2015; 6: 11652-63.
59. Gregory PA, Bert AG, Paterson EL, et al., The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.
60. Haiman CA, Le Marchand L, Yamamato J, et al., A common genetic risk factor for colorectal and prostate cancer. Nat Genet 2007; 39: 954-6.
61. Ghoussaini M, Song H, Koessler T, et al., Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008; 100: 962-6.
62. Pomerantz MM, Ahmadiyeh N, Jia L, et al., The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009; 41: 882-4.
63. Ling H, Spizzo R, Atlasi Y, et al., CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res 2013; 23: 1446-61.
64. Qiu M, Xu Y, Yang X, et al., CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumour Biol 2014; 35: 5375-80.
65. Cai Y, He J, Zhang D., Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Onco Targets Ther 2015; 8: 2657-64.
66. Zhang X, Xu Y, He C, et al., Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 2015; 111: 834-9.
67. Wang CY, Hua L, Yao KH, et al., Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis. Int J Clin Exp Pathol 2015; 8: 779-85.
68. Fischer KR, Durrans A, Lee S, et al., Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 2015; 527: 472-6.
69. Zheng X, Carstens JL, Kim J, et al., Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 2015; 527: 525-30.
70. Beltran M, Puig I, Pena C, et al., A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev 2008; 22: 756-69.
71. Zhuang J, Lu Q, Shen B, et al., TGFbeta1 secreted by cancer-Associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci Rep 2015; 5: 11924
72. Pandey GK, Mitra S, Subhash S, et al., The risk-Associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell 2014; 26: 722-37.
73. Hu P, Chu J, Wu Y, et al., NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2. Oncotarget 2015; 6: 32410-25.
74. Wang Y, He L, Du Y, et al., The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell 2015; 16: 413-25.
75. Wu J, Zhang J, Shen B, et al., Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J Exp Clin Cancer Res 2015; 34: 116
76. Wang F, Li X, Xie X, et al., UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett 2008; 582: 1919-27.
77. Fan Y, Shen B, Tan M, et al., Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. Febs J 2014; 281: 1750-8.
78. Fang Z, Wu L, Wang L, et al., Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117: 89-95.
79. Li JY, Ma X, Zhang CB., Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 7938-44.
80. Ni B, Yu X, Guo X, et al., Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol 2015; 47: 1329-38.
81. Huang J, Zhou N, Watabe K, et al., Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 2014; 5: e1008
82. Wang Y, Chen W, Yang C, et al., Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol 2012; 41: 276-84.
83. Sun M, Xia R, Jin F, et al., Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol 2014; 35: 1065-73.
84. Lu KH, Li W, Liu XH, et al., Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer 2013; 13: 461
85. Li Z, Li C, Liu C, et al., Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior. Pituitary 2015; 18: 42-7.
86. Mondal T, Subhash S, Vaid R, et al., MEG3 long noncoding RNA regulates the TGF-beta pathway genes through formation of RNA-DNA triplex structures. Nat Commun 2015; 6: 7743
87. Zhou Y, Zhong Y, Wang Y, et al., Activation of p53 by MEG3 non-coding RNA. J Biol Chem 2007; 282: 24731-42.
88. Peng W, Si S, Zhang Q, et al., Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. J Exp Clin Cancer Res 2015; 34: 79
89. Gordon FE, Nutt CL, Cheunsuchon P, et al., Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology 2010; 151: 2443-52.
90. Lin L, Gu ZT, Chen WH, et al., Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis. Diagn Pathol 2015; 10: 14
91. Nie FQ, Sun M, Yang JS, et al., Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther 2015; 14: 268-77.
92. Qiu JJ, Lin YY, Ding JX, et al., Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer. Int J Oncol 2015; 46: 2497-505.
93. Hua L, Wang CY, Yao KH, et al., High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol 2015; 8: 3076-82.
94. Flockhart RJ, Webster DE, Qu K, et al., BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. Genome Res 2012; 22: 1006-14.
95. Guo Q, Zhao Y, Chen J, et al., BRAF-Activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition. Oncol Lett 2014; 8: 869-75.
96. Shi Y, Liu Y, Wang J, et al., Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 Expression. PLoS One 2015; 10: e0122679
97. Su S, Gao J, Wang T, et al., Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma. Tumour Biol 2015; 36: 7205-11.
98. Li L, Zhang L, Zhang Y, et al., Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer. Biomed Pharmacother 2015; 72: 109-12.
99. Sun M, Liu XH, Wang KM, et al., Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Mol Cancer 2014; 13: 68
100. Meijer D, van Agthoven T, Bosma PT, et al., Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells. Mol Cancer Res 2006; 4: 379-86.
101. Godinho M, Meijer D, Setyono-Han B, et al., Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells. J Cell Physiol 2011; 226: 1741-9.
102. Xing Z, Lin A, Li C, et al., lncRNA directs cooperative epigenetic regulation downstream of chemokine signals. Cell 2014; 159: 1110-25.
103. Zalfa F, Giorgi M, Primerano B, et al., The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 2003; 112: 317-27.
104. Hu T, Lu YR., BCYRN1, a c-MYC-Activated long non-coding RNA, regulates cell metastasis of non-small-cell lung cancer. Cancer Cell Int 2015; 15: 36
105. Kim T, Cui R, Jeon YJ, et al., Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci U S A 2014; 111: 4173-8.
106. Luo J, Tang L, Zhang J, et al., Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer. Tumour Biol 2014; 35: 11541-9.
107. Wang F, Xie C, Zhao W, et al., Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Clin Exp Med 2015.
108. Zhang Y, Ma M, Liu W, et al., Enhanced expression of long noncoding RNA CARLo-5 is associated with the development of gastric cancer. Int J Clin Exp Pathol 2014; 7: 8471-9.
109. Yang F, Xue X, Bi J, et al., Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol 2013; 139: 437-45.
110. Xiang JF, Yin QF, Chen T, et al., Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res 2014; 24: 513-31.
111. He X, Tan X, Wang X, et al., C-Myc-Activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol 2014; 35: 12181-8.
112. Deng L, Yang SB, Xu FF, et al., Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res 2015; 34: 18
113. Sakurai K, Reon BJ, Anaya J, et al., The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus. Mol Cancer Res 2015; 13: 828-38.
114. Qi HL, Li CS, Qian CW, et al., The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma. Tumour Biol 2015.
115. Xu SP, Zhang JF, Sui SY, et al., Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer. Tumour Biol 2015.
116. Wei G, Luo H, Sun Y, et al., Transcriptome profiling of esophageal squamous cell carcinoma reveals a long noncoding RNA acting as a tumor suppressor. Oncotarget 2015; 6: 17065-80.
117. Tu ZQ, Li RJ, Mei JZ, et al., Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma. Int J Clin Exp Pathol 2014; 7: 4303-9.
118. Hu L, Ye H, Huang G, et al., Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21. Tumour Biol In press
119. Cao S, Liu W, Li F, et al., Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Int J Clin Exp Pathol 2014; 7: 6776-83.
120. Zhao X, Wang P, Liu J, Zheng J, Liu Y, Chen J, Xue Y., Gas5 Exerts Tumor-suppressive Functions in Human Glioma Cells by Targeting miR-222. Mol Ther 2015; 23: 1899-911.
121. Hu Y, Wang J, Qian J, et al., Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. Cancer Res 2014; 74: 6890-902.
122. Matouk IJ, DeGroot N, Mezan S, et al., The H19 non-coding RNA is essential for human tumor growth. PLoS One 2007; 2: e845
123. Fellig Y, Ariel I, Ohana P, et al., H19 expression in hepatic metastases from a range of human carcinomas. J Clin Pathol 2005; 58: 1064-8.
124. Shi Y, Wang Y, Luan W, et al., Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One 2014; 9: e86295
125. Zhuang M, Gao W, Xu J, et al., The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem Biophys Res Commun 2014; 448: 315-22.
126. Tsang WP, Ng EK, Ng SS, et al., Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010; 31: 350-8.
127. Esteves LI, Javaroni AC, Nishimoto IN, et al., DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas? Mol Carcinog 2005; 44: 102-10.
128. Kallen AN, Zhou XB, Xu J, et al., The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101-12.
129. Nakagawa T, Endo H, Yokoyama M, et al., Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem Biophys Res Commun 2013; 436: 319-24.
130. Liu XH, Liu ZL, Sun M, et al., The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC Cancer 2013; 13: 464
131. Milhem MM, Knutson T, Yang S, et al., Correlation of MTDH/AEG-1 and HOTAIR Expression with Metastasis and Response to Treatment in Sarcoma Patients. J Cancer Sci Ther 2011; S5
132. Kim K, Jutooru I, Chadalapaka G, et al., HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 2013; 32: 1616-25.
133. Zhang H, Zhao L, Wang YX, et al., Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma. Tumour Biol 2015;
134. Cheng Y, Jutooru I, Chadalapaka G, et al., The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. Oncotarget 2015; 6: 10840-52.
135. Li Z, Zhao X, Zhou Y, et al., The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med 2015; 13: 84
136. Tsang FH, Au SL, Wei L, et al., Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b. Liver Int 2015; 35: 1597-606.
137. Quagliata L, Matter MS, Piscuoglio S, et al., Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology 2014; 59: 911-23.
138. Panzitt K, Tschernatsch MM, Guelly C, et al., Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 2007; 132: 330-42.
139. Wang J, Liu X, Wu H, et al., CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366-83.
140. Matouk IJ, Abbasi I, Hochberg A, et al., Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol 2009; 21: 688-92.
141. Zhao Y, Guo Q, Chen J, et al., Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep 2014; 31: 358-64.
142. Peng W, Gao W, Feng J., Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Med Oncol 2014; 31: 346
143. Sun XH, Yang LB, Geng XL, et al., Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma. Int J Clin Exp Pathol 2015; 8: 2994-3000.
144. Jiang S, Wang HL, Yang J., Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer. Int J Clin Exp Pathol 2015; 8: 806-11.
145. Richards EJ, Zhang G, Li ZP, et al., Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) beta: LncRNA-hit-mediated TGFbeta-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem 2015; 290: 6857-67.
146. Ren S, Liu Y, Xu W, et al., Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol 2013; 190: 2278-87.
147. Fan Y, Shen B, Tan M, et al., TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res 2014; 20: 1531-41.
148. Hirata H, Hinoda Y, Shahryari V, et al., Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Res 2015; 75: 1322-31.
149. Yang L, Bai HS, Deng Y, et al., High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci 2015; 19: 3187-93.
150. Hu L, Wu Y, Tan D, et al., Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2015; 34: 7
151. Pang EJ, Yang R, Fu XB, et al., Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol 2015; 36: 2403-7.
152. Zhai H, Chen QJ, Chen BD, et al., Long noncoding RNA MALAT1 as a putative biomarker of lymph node metastasis: a meta-Analysis. Int J Clin Exp Med 2015; 8: 7648-54.
153. Yin DD, Liu ZJ, Zhang E, et al., Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumour Biol 2015; 36: 4851-9.
154. Wang C, Yan G, Zhang Y, et al., Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1. Neoplasma 2015; 62: 541-9.
155. Xue S, Li QW, Che JP, et al., Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma. Int J Clin Exp Pathol 2015; 8: 3765-74.
156. Pan LJ, Zhong TF, Tang RX, et al., Upregulation and clinicopathological significance of long non-coding NEAT1 RNA in NSCLC tissues. Asian Pac J Cancer Prev 2015; 16: 2851-5.
157. Guo S, Chen W, Luo Y, et al., Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. Int J Clin Exp Pathol 2015; 8: 5395-402.
158. Zhen L, Yun-Hui L, Hong-Yu D, et al., Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Tumour Biol 2015;
159. Li Y, Li Y, Chen W, et al., NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget 2015; 6: 27641-50.
160. Chakravarty D, Sboner A, Nair SS, et al., The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun 2014; 5: 5383
161. Krawczyk M, Emerson BM., p50-Associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-kappaB complexes. Elife 2014; 3: e01776
162. Qian M, Yang X, Li Z, et al., P50-Associated COX-2 extragenic RNA (PACER) overexpression promotes proliferation and metastasis of osteosarcoma cells by activating COX-2 gene. Tumour Biol 2015;
163. Malik R, Patel L, Prensner JR, et al., The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Mol Cancer Res 2014; 12: 1081-7.
164. Yang Z, Zhi Q, Wang D, et al., Long noncoding RNA C21orF96 promotes the migration, invasion and lymph node metastasis in gastric cancer. Anticancer Agents Med Chem 2015; CrossRef][10.2174/1871520616666151116122921]
165. Liu H, Lv Z, Guo E., Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition. Int J Clin Exp Pathol 2015; 8: 9140-6.
166. Xie M, Nie FQ, Sun M, et al., Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition. J Transl Med 2015; 13: 250
167. Peng W, Wu G, Fan H, et al., Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer. Tumour Biol 2015; 36: 6751-8.
168. Tian Y, Zhang X, Hao Y, et al., Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res 2014; 24: 335-41.
169. Wang F, Ying HQ, He BS, et al., Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 2015; 6: 7899-917.
170. Zheng Q, Wu F, Dai WY, et al., Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol 2015; 17: 640-6.
171. Yan X, Hu Z, Feng Y, et al., Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell 2015; 28: 529-40.
172. White NM, Cabanski CR, Silva-Fisher JM, et al., Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer. Genome Biol 2014; 15: 429
173. Diederichs S., The four dimensions of noncoding RNA conservation. Trends Genet 2014; 30: 121-3.
174. Ulitsky I, Shkumatava A, Jan CH, et al., Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 2011; 147: 1537-50.